1. Update. WHO guidelines approved by the guidelines review committee;WHO Treatment Guidelines for Drug-Resistant Tuberculosis,2016
2. CDC, and IDSA update recommendations on the treatment of tuberculosis;Neff;Am Fam Physician,2003
3. Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients as district tuberculosis centre Rajkot;Piparva;Perspect Clin Res,2018
4. Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh;Heysell;Eur Respir J,2018
5. Adverse effects of aminoglycosides in children with drug resistant tuberculosis;Shah;Infect Dis,2018